Home » Topics » Regulatory

Regulatory
RSS

Zovirax approved by FDA for recurrent cold sores

Jan. 8, 2003

Zyvox approved for bacterial infections in infants and children

Jan. 8, 2003

Endo submits NDA for extended-release oxymorphone

Jan. 8, 2003

Metformin XT NDA submitted for type 2 diabetes

Jan. 8, 2003

Restasis receives FDA approval

Jan. 7, 2003

Topamax sNDA submitted for migraine prevention

Jan. 7, 2003

Zindaclin receives further E.U. approvals

Jan. 7, 2003

Humira approved by FDA for RA

Jan. 3, 2003

Foradil Certihaler filed for approval in the U.S.

Jan. 3, 2003

Novartis files supplemental NDA for Starlix

Jan. 3, 2003